STAT

SEPTEMBER 8, 2023

On a Friday afternoon in July, as many New Yorkers fled the scorching city streets, a couple of dozen out-of-towners descended on Times Square. They came bearing gold letter balloons spelling out LFVN, the stock symbol for LifeVantage, the company they’d come to promote, and foam cutouts of its navy blue supplement bottles. LifeVantage’s chief executive officer, Steve Fife, rang the Nasdaq exchange’s closing bell, a celebration of the Utah-based company’s new products

Vaccines 361

Vaccines 361

PharmaVoice

SEPTEMBER 8, 2023

The PASTEUR Act is likely heading for another legislative blow, but advocates say they see a future for the mechanism to fund the battle against antimicrobial resistance.

130

130

STAT

SEPTEMBER 8, 2023

While it’s widely accepted that the pharma industry is innovative in R&D, it is also true that it can be slow at embracing technological revolutions. Many people have criticized pharma companies for being slow to adopt AI. Indeed, some CEOs I talk to are concerned about too widely adopting AI, citing fears of unknown threats. But as the CEO of Sanofi, I don’t believe those challenges should guide our thinking or adoption of AI in the pharma business, as AI has the potential to

359

359

The Pharmacist

SEPTEMBER 8, 2023

The Pharmacists’ Defence Association (PDA) has urged pharmacists to ask their employers to sign the Covid-19 safety pledge, which includes a commitment to ensuring that all workers who test positive for the virus are both asked to self-isolate and given adequate support to stay at home. The representative body itself has recently signed the pledge, […] The post Ask employers to sign Covid-19 safety pledge, urges PDA appeared first on The Pharmacist.

125

125

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 8, 2023

Heart disease is killing fewer Americans overall, however, cardiovascular deaths where obesity was listed as a key contributing factor have tripled between 1999 and 2020, according to a new study published Wednesday in the Journal of the American Heart Association. And, Black women had the highest mortality rate out of all the population groups studied.

353

353

Pharma Times

SEPTEMBER 8, 2023

The company will use its AI technology during a sub-study to analyse the effect of lansoprazole - News - PharmaTimes

150

150

Pharma Times

SEPTEMBER 8, 2023

Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate - News - PharmaTimes

142

142

STAT

SEPTEMBER 8, 2023

A diagnosis of ALS has long been seen as a death sentence. But in recent years, progress in the world of ALS research and drug development has come to embody a conundrum with far broader implications: The balance between moving aggressively on promising new cures and guarding against false hope.

Drug Development 334

Drug Development 334

BioPharma Dive

SEPTEMBER 8, 2023

Shape uses machine learning and high throughput screening to identify new AAV capsids in ways the company’s CEO compares to the generative AI tools Midjourney and DALLE-2.

114

114

STAT

SEPTEMBER 8, 2023

A large independent group of oncologists in Philadelphia is suing the area’s dominant hospital system, Jefferson Health, alleging the system is violating federal antitrust and kickback laws by creating a “concerted campaign to eliminate” the group’s “presence in the oncology marketplace.” The lawsuit resurfaces longstanding concerns associated with hospitals buying up physician groups and then forcing those physicians to refer patients to the hospitals&#

Hospitals 294

Hospitals Chemotherapy 294

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

SEPTEMBER 8, 2023

Worth up to $840 million, the collaboration will give Alexion access to Verge Genomics’ platform, which uses human tissue data to find drug targets for diseases that degrade the nerve system.

112

112

STAT

SEPTEMBER 8, 2023

Alzheimer’s isn’t funny. But comedy can still be a weapon in the fight against this deadly degenerative disease. Since 2012, comedian and filmmaker Lauren Miller Rogen and her husband, actor and comedian Seth Rogen, have used humor to help raise awareness for Alzheimer’s disease and funds for at-home caregiving through their nonprofit Hilarity for Charity.

293

293

BioPharma Dive

SEPTEMBER 8, 2023

The PASTEUR Act could be heading for another legislative blow, but advocates say they see a future for the mechanism to fund research into antimicrobial resistance.

112

112

STAT

SEPTEMBER 8, 2023

After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much has been discussed about the drugs that were selected and the magnitude of price decreases that can be achieved. Less attention has been given to what this all means for Medicare beneficiaries. The negotiation, informed by confidential data from manufacturers and analysis by the Centers for Medicare and Medicaid Services, will result in a maximum fair price for each drug, which will be announced Sep

Drug Pricing 291

Drug Pricing 291

PharmExec

SEPTEMBER 8, 2023

With an organization's future commercial success under its remit, the NPP function has rapidly progressed to a prominent role in the biopharma industry—but evidence-generation strategies must evolve with an eye toward emerging trends and technologies.

98

98

STAT

SEPTEMBER 8, 2023

Annie Larsson, 40, is no stranger to chronic conditions. She was diagnosed with type 1 diabetes at a young age and had it “completely managed” for years. Then, right before the Covid pandemic began, she was diagnosed with Graves’ disease, a condition that can make a person’s thyroid overactive. A thyroid removal surgery later, all she had to worry about was taking her thyroid hormone replacement medication every day — a to-do she was accustomed to because of he

Diabetes 284

Diabetes 284

European Pharmaceutical Review

SEPTEMBER 8, 2023

Eli Lilly ’s Mounjaro (tirzepatide), has been recommended to treat poorly controlled type 2 diabetes in adults alongside diet and exercise. National Institute for Health and Care Excellence (NICE) final draft guidance recommends tirzepatide as a new treatment option for this indication. Compared with semaglutide , insulin therapy or a placebo, tirzepatide demonstrated that 81 percent to 97 percent of people achieved better glucose control in clinical trials.

Diabetes 98

Diabetes 98

STAT

SEPTEMBER 8, 2023

Good morning, Pharmalittle family! Adam Feuerstein here, filling in for Ed. My morning coffee was brewed with Peru Cajamarca beans, sourced by Equator and lightly roasted to reveal “notes of almond, tamarind and white grape.” Honestly, I’m not getting any of those flavors, but it’s still a damn good cup of joe. Very smooth.

Diabetes 211

Diabetes 211

PharmExec

SEPTEMBER 8, 2023

Lisa LeCointe-Cephas, SVP, chief ethics and compliance officer and office of general counsel, human health, Merck, uses her unique style of leadership—stop, drop, and roll—while elevating voices that need to be heard.

94

94

STAT

SEPTEMBER 8, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

178

178

The Pharmacist

SEPTEMBER 8, 2023

Expanding pharmacy technicians’ scope of practice, including by allowing them to use patient group directions (PGDs), is expected to increase the attractiveness of a career in community pharmacy, the president of the Association of Pharmacy Technicians UK (APTUK) has told The Pharmacist. Claire Steele said that opportunities in general practice had enabled pharmacy technicians to […] The post PGDs for pharmacy technicians will make community career ‘more attractive’ appeared first on The P

Pharmacy Technician 95

Pharmacy Technician Community Pharmacies 95

Pharmaceutical Technology

SEPTEMBER 8, 2023

Eloxx has submitted an IND for a pivotal trial to study its Alport syndrome therapy ELX-02 following a positive Phase II data readout.

105

105

European Pharmaceutical Review

SEPTEMBER 8, 2023

The section on environmental monitoring (EM) in Annex 1 states that “The adoption of suitable rapid or automated monitoring systems should be considered by manufacturers in order to expedite the detection of microbiological contamination issues and to reduce the risk to product”. 1 This article therefore considers some of the possible systems that can be applied in EM.

80

80

Pharmaceutical Technology

SEPTEMBER 8, 2023

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

97

97

Drug Channels

SEPTEMBER 8, 2023

Today’s guest post comes from Nasir Ali, Chief Product Officer at CareMetx. Nasir discusses how hubs help patients initiate and adhere to drug therapies. Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs.

Pharmaceutical Manufacturing 74

Pharmaceutical Manufacturing 74

Pharmaceutical Technology

SEPTEMBER 8, 2023

The European Commission granted expanded indication approval for Merck’s Ebola vaccine, Ervebo, to include children aged one year or above.

Vaccines 96

Vaccines 96

World Pharma News

SEPTEMBER 8, 2023

Many people with diseases such as cancer or diabetes or those who have had a heart attack or stroke also suffer from depression. How effective are antidepressants for these patients? And are they just as safe for these people as for those without physical health problems? Researchers from Charité - Universitätsmedizin Berlin and Aarhus University in Denmark have teamed up to investigate these questions.

Diabetes 81

Diabetes 81

Pharmaceutical Technology

SEPTEMBER 8, 2023

The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.

Diabetes 98

Diabetes 98

pharmaphorum

SEPTEMBER 8, 2023

Combining new and existing immunity: A 3D approach to killing cancer Mike.

Immunity 116

Immunity Immunization 116

Outsourcing Pharma

SEPTEMBER 8, 2023

A benchtop DNA sequencer developed by the U.S. DNA sequencing company Element Biosciences, Inc., has seen sales grow by triple digits and has received more than 100 orders since its launch in March 2022.

98

98

European Pharmaceutical Review

SEPTEMBER 8, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has provided data on its assessment of clinical trial authorisation (CTA) applications and substantial amendments for the period August 2022 to September 2023. Part of the main data highlighted included the performance metrics for regulatory CTA applications. In August 2023, the MHRA assessed 116 clinical trial authorisation (CTA) applications, its presentation revealed.

72

72

Outsourcing Pharma

SEPTEMBER 8, 2023

The U.S. company Nimbus Therapeutics has raised $210 million in a financing round to fund the development of small molecule drugs powered by computational drug discovery.

97

97

pharmaphorum

SEPTEMBER 8, 2023

Seagen partners Nurix on 'degrader-antibody conjugates' Phil.

103

103

BioPharma Dive

SEPTEMBER 8, 2023

Roche says it won’t be able to launch the subcutaneous version of the drug until 2024 as it works with the FDA on manufacturing “updates.

65

65

Pharmafile

SEPTEMBER 8, 2023

Vaxart has announced topline data from its phase 2 challenge study which assessed its oral tablet monovalent norovirus vaccine candidate. The study met five out of its six primary endpoints and the vaccine was safe and well tolerated with no vaccine-related serious adverse events reported. The study enrolled 165 healthy adult patients who were randomised […] The post Vaxart shares topline data from phase 2 study of norovirus vaccine candidate appeared first on Pharmafile.

Vaccines 58

Vaccines 58